Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Trylesinski

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Lancet (London, England)|May 21, 1994
Magnesium and myocardial infarctionB Toussaint, A Trylesinski
Presse Medicale (Paris, France : 1983)|February 7, 1998
[Crack: an inhalated form of cocaine]J Schlatter, G Nester, A Trylesinski
Annales De Cardiologie Et D'Angeiologie|September 1, 1995
[Malignant non-Hodgkin lymphoma of cardiac localization. Apropos of a case]M Ghannem, S Godard, A Trylesinski, et al.
Pathologie-Biologie|March 1, 1989
[Meningococcal arthritis (serogroup A) contracted during a pilgrimage to Mecca]A Trylesinski, M P Le Pennec, M Guibourdenche, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 24, 2001
Effect of highly active antiretroviral therapy on expression of interleukin-10 and interleukin-12 in HIV-infected patientsY Taoufik, I Peguillet, M G de Goër, et al.
European Journal of Gastroenterology & Hepatology|July 1, 1995
Intestinal histoplasmosis in AIDS patients: report of three cases observed in France and review of the literatureA Trylesinski, F Carbonnel, O Bouchaud, et al.
The Journal of Allergy and Clinical Immunology|November 18, 1998
Nelfinavir-induced urticaria and successful desensitizationP Demoly, D Messaad, A Trylesinski, et al.
Therapeutic Drug Monitoring|July 31, 2001
Pharmacokinetics and resistance mutations affect virologic response to ritonavir/saquinavir-containing regimensI Pellegrin, D Breilh, V Birac, et al.
Journal of Clinical Microbiology|July 6, 2000
Early virological failure in naive human immunodeficiency virus patients receiving saquinavir (soft gel capsule)-stavudine-zalcitabine (MIKADO trial) is not associated with mutations conferring viral resistanceM Mouroux, A Yvon-Groussin, G Peytavin, et al.
Journal of Viral Hepatitis|March 16, 2013
Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis BY Wang, S Thongsawat, E J Gane, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Lancet (London, England)|May 21, 1994
Magnesium and myocardial infarctionB Toussaint, A Trylesinski
Presse Medicale (Paris, France : 1983)|February 7, 1998
[Crack: an inhalated form of cocaine]J Schlatter, G Nester, A Trylesinski
Annales De Cardiologie Et D'Angeiologie|September 1, 1995
[Malignant non-Hodgkin lymphoma of cardiac localization. Apropos of a case]M Ghannem, S Godard, A Trylesinski, et al.
Pathologie-Biologie|March 1, 1989
[Meningococcal arthritis (serogroup A) contracted during a pilgrimage to Mecca]A Trylesinski, M P Le Pennec, M Guibourdenche, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 24, 2001
Effect of highly active antiretroviral therapy on expression of interleukin-10 and interleukin-12 in HIV-infected patientsY Taoufik, I Peguillet, M G de Goër, et al.
European Journal of Gastroenterology & Hepatology|July 1, 1995
Intestinal histoplasmosis in AIDS patients: report of three cases observed in France and review of the literatureA Trylesinski, F Carbonnel, O Bouchaud, et al.
The Journal of Allergy and Clinical Immunology|November 18, 1998
Nelfinavir-induced urticaria and successful desensitizationP Demoly, D Messaad, A Trylesinski, et al.
Therapeutic Drug Monitoring|July 31, 2001
Pharmacokinetics and resistance mutations affect virologic response to ritonavir/saquinavir-containing regimensI Pellegrin, D Breilh, V Birac, et al.
Journal of Clinical Microbiology|July 6, 2000
Early virological failure in naive human immunodeficiency virus patients receiving saquinavir (soft gel capsule)-stavudine-zalcitabine (MIKADO trial) is not associated with mutations conferring viral resistanceM Mouroux, A Yvon-Groussin, G Peytavin, et al.
Journal of Viral Hepatitis|March 16, 2013
Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis BY Wang, S Thongsawat, E J Gane, et al.
Pageof 2